Literature DB >> 19066180

Dual energy computed tomography in tophaceous gout.

H K Choi1, A M Al-Arfaj, A Eftekhari, P L Munk, K Shojania, G Reid, S Nicolaou.   

Abstract

OBJECTIVE: To evaluate the potential utility of a dual energy CT (DECT) scan in assessing urate deposits among patients with tophaceous gout, and obtain computerised quantification of tophus volume in peripheral joints.
METHODS: 20 consecutive patients with tophaceous gout and 10 control patients with other arthritic conditions were included. DECT scans were performed using a renal stone colour-coding protocol that specifically assessed the chemical composition of the material (ie, urate coloured in red, calcium coloured in blue). An automated volumetric assessment of DECT was used to measure the volume of urate deposits in all peripheral joint areas.
RESULTS: All 20 patients with gout showed red colour-coded urate deposits on their DECT scans, whereas none of 10 controls showed urate deposits. DECT scans revealed a total of 440 areas of urate deposition in 20 patients, whereas physical examination showed 111 areas of urate deposition (mean 22 vs 6 per patient, respectively, p<0.001). Total urate volume in a given patient ranged from 0.63 cm(3) to 249.13 cm(3), with a mean of 40.20 cm(3).
CONCLUSIONS: DECT scans can produce obvious colour displays for urate deposits and help to identify subclinical tophus deposits. Furthermore, tophus volume can be measured by DECT scans through an automated volume estimation procedure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066180     DOI: 10.1136/ard.2008.099713

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  91 in total

1.  Differentiation of hemorrhage from iodinated contrast in different intracranial compartments using dual-energy head CT.

Authors:  C M Phan; A J Yoo; J A Hirsch; R G Nogueira; R Gupta
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

2.  Cascaded systems analysis of noise and detectability in dual-energy cone-beam CT.

Authors:  Grace J Gang; Wojciech Zbijewski; J Webster Stayman; Jeffrey H Siewerdsen
Journal:  Med Phys       Date:  2012-08       Impact factor: 4.071

Review 3.  Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals.

Authors:  Hisataka Kobayashi; Michelle R Longmire; Mikako Ogawa; Peter L Choyke
Journal:  Chem Soc Rev       Date:  2011-05-23       Impact factor: 54.564

Review 4.  Imaging in gout: A review of the recent developments.

Authors:  Priya Varghese Chowalloor; Teck K Siew; Helen Isobel Keen
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-08       Impact factor: 5.346

5.  Musculoskeletal imaging of the inflammatory and degenerative joints: current status and perspectives.

Authors:  Fausto Salaffi; Marina Carotti; Antonio Barile
Journal:  Radiol Med       Date:  2019-02-27       Impact factor: 3.469

Review 6.  The gouty tophus: a review.

Authors:  Ashika Chhana; Nicola Dalbeth
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

7.  Radiologic evidence of symmetric and polyarticular monosodium urate crystal deposition in gout - A cluster pattern analysis of dual-energy CT.

Authors:  Chio Yokose; Nicola Dalbeth; Jie Wei; Savvas Nicolaou; F Joseph Simeone; Scott Baumgartner; Maple Fung; Yuqing Zhang; Hyon K Choi
Journal:  Semin Arthritis Rheum       Date:  2019-07-11       Impact factor: 5.532

8.  Methods of assessment of tophus and bone erosions in gout using dual-energy CT: reproducibility analysis.

Authors:  Dan Shi; Jian-Xia Xu; Hua-Xiang Wu; Ying Wang; Qi-Jing Zhou; Ri-Sheng Yu
Journal:  Clin Rheumatol       Date:  2014-06-17       Impact factor: 2.980

Review 9.  Gout in the Spine: Imaging, Diagnosis, and Outcomes.

Authors:  Michael Toprover; Svetlana Krasnokutsky; Michael H Pillinger
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.592

Review 10.  Gout. Novel therapies for treatment of gout and hyperuricemia.

Authors:  Robert Terkeltaub
Journal:  Arthritis Res Ther       Date:  2009-07-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.